Balchem (NASDAQ:BCPC) Trading Down 85.7% - Here's What Happened

Shares of Balchem Co. (NASDAQ:BCPC - Get Free Report) were down 85.7% during trading on Tuesday . The company traded as low as $156.45 and last traded at $22.46. Approximately 65,200 shares were traded during trading, a decline of 50% from the average daily volume of 129,356 shares. The stock had previously closed at $156.92.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on BCPC shares. Sidoti upgraded shares of Balchem to a "hold" rating in a research note on Tuesday, February 25th. HC Wainwright reiterated a "buy" rating and set a $190.00 target price on shares of Balchem in a report on Monday, February 24th. Finally, StockNews.com downgraded Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th.

Balchem Stock Performance

The business's 50 day simple moving average is $164.09 and its two-hundred day simple moving average is $167.16. The firm has a market capitalization of $5.00 billion, a P/E ratio of 39.09, a price-to-earnings-growth ratio of 4.41 and a beta of 0.75. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19.

Balchem (NASDAQ:BCPC - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.22 EPS for the quarter, missing the consensus estimate of $1.25 by ($0.03). The firm had revenue of $250.52 million during the quarter, compared to the consensus estimate of $245.70 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. Sell-side analysts anticipate that Balchem Co. will post 4.64 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. KBC Group NV raised its position in shares of Balchem by 24.1% during the 1st quarter. KBC Group NV now owns 1,582 shares of the basic materials company's stock valued at $263,000 after purchasing an additional 307 shares during the period. Yorktown Management & Research Co Inc purchased a new position in shares of Balchem in the first quarter valued at about $241,000. Cambridge Investment Research Advisors Inc. boosted its stake in shares of Balchem by 243.2% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 9,390 shares of the basic materials company's stock worth $1,559,000 after acquiring an additional 6,654 shares during the period. Cardinal Capital Management grew its position in shares of Balchem by 4.3% during the first quarter. Cardinal Capital Management now owns 25,842 shares of the basic materials company's stock worth $4,290,000 after purchasing an additional 1,071 shares in the last quarter. Finally, QRG Capital Management Inc. raised its stake in Balchem by 8.9% during the 1st quarter. QRG Capital Management Inc. now owns 5,645 shares of the basic materials company's stock valued at $937,000 after purchasing an additional 462 shares during the period. 87.91% of the stock is currently owned by institutional investors.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.